Advertisement
Abstract| Volume 18, ISSUE 6, SUPPLEMENT , S14, June 2016

Multi-Pathogen Cytotoxic T-Lymphocytes to Enhance Immunity Post-Allogeneic Stem Cell Transplantation (HSCT)

  • E. Blyth
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    BMT Unit, Westmead Hospital, Westmead, New South Wales, Australia

    University of Sydney, Sydney, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • C. Ma
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    BMT Unit, Westmead Hospital, Westmead, New South Wales, Australia

    University of Sydney, Sydney, New South Wales, Australia
    Search for articles by this author
  • L.E. Clancy
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • P. Shyam
    Affiliations
    BMT Unit, Westmead Hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • R. Simms
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • J. Burgess
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • K. Micklethwaite
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    BMT Unit, Westmead Hospital, Westmead, New South Wales, Australia

    University of Sydney, Sydney, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
  • D. Gottlieb
    Affiliations
    Leukaemia Cell Therapy, Westmead Institute of Medical Research, Westmead, New South Wales, Australia

    BMT Unit, Westmead Hospital, Westmead, New South Wales, Australia

    University of Sydney, Sydney, New South Wales, Australia

    Sydney cell and gene therapy laboratory, Westmead hospital, Westmead, New South Wales, Australia
    Search for articles by this author
DOI:https://doi.org/10.1016/j.jcyt.2016.03.037
Multi-Pathogen Cytotoxic T-Lymphocytes to Enhance Immunity Post-Allogeneic Stem Cell Transplantation (HSCT)
Previous ArticleVaccination with Wilms' Tumor Antigen (WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma
Next ArticleSystemic Autologous Mesenchymal Stem Cell Therapy for Immunomodulation in Resistant Myasthenia Gravis
      Aim: We present data from a phase I/II clinical trial administering HSCT patients T cells specific for seven common opportunistic pathogens to facilitate specific immune reconstitution.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Identification

      DOI: https://doi.org/10.1016/j.jcyt.2016.03.037

      Copyright

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX